These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 18525305

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A phase II study of modified FOLFOX as first-line chemotherapy in elderly patients with advanced gastric cancer.
    Zhao JG, Qiu F, Xiong JP, Zhang L, Xiang XJ, Yu F, Yan J, Zhan ZY, Feng M.
    Anticancer Drugs; 2009 Apr; 20(4):281-6. PubMed ID: 19247179
    [Abstract] [Full Text] [Related]

  • 3. A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer.
    Oh SY, Kwon HC, Seo BG, Kim SH, Kim JS, Kim HJ.
    Acta Oncol; 2007 Apr; 46(3):336-41. PubMed ID: 17450469
    [Abstract] [Full Text] [Related]

  • 4. Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer.
    Al-Batran SE, Atmaca A, Hegewisch-Becker S, Jaeger D, Hahnfeld S, Rummel MJ, Seipelt G, Rost A, Orth J, Knuth A, Jaeger E.
    J Clin Oncol; 2004 Feb 15; 22(4):658-63. PubMed ID: 14966088
    [Abstract] [Full Text] [Related]

  • 5. Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC).
    Cavanna L, Artioli F, Codignola C, Lazzaro A, Rizzi A, Gamboni A, Rota L, Rodinò C, Boni F, Iop A, Zaniboni A.
    Am J Clin Oncol; 2006 Aug 15; 29(4):371-5. PubMed ID: 16891864
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A pilot study of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) as first-line chemotherapy in advanced or recurrent gastric cancer.
    Luo HY, Xu RH, Zhang L, Li YH, Shi YX, Lin TY, Han B, Wang F, Qiu MZ, He YJ, Guan ZZ.
    Chemotherapy; 2008 Aug 15; 54(3):228-35. PubMed ID: 18560231
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.
    De Vita F, Orditura M, Matano E, Bianco R, Carlomagno C, Infusino S, Damiano V, Simeone E, Diadema MR, Lieto E, Castellano P, Pepe S, De Placido S, Galizia G, Di Martino N, Ciardiello F, Catalano G, Bianco AR.
    Br J Cancer; 2005 May 09; 92(9):1644-9. PubMed ID: 15856038
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer.
    Wang F, Wang Z, Zhou N, An X, Xu R, He Y, Li Y.
    Am J Clin Oncol; 2011 Aug 09; 34(4):401-5. PubMed ID: 21791984
    [Abstract] [Full Text] [Related]

  • 12. Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer.
    Hochster H, Chachoua A, Speyer J, Escalon J, Zeleniuch-Jacquotte A, Muggia F.
    J Clin Oncol; 2003 Jul 15; 21(14):2703-7. PubMed ID: 12860947
    [Abstract] [Full Text] [Related]

  • 13. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer.
    Kundel Y, Purim O, Figer A, Stemmer SM, Tichler T, Sulkes J, Sulkes A, Brenner B.
    Med Sci Monit; 2008 Apr 15; 14(4):CR190-5. PubMed ID: 18376346
    [Abstract] [Full Text] [Related]

  • 14. Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer.
    Popov I, Radosevic-Jelic L, Jezdic S, Milovic M, Borojevic N, Stojanovic S, Stankovic V, Josifovski T, Kezic I.
    J BUON; 2008 Apr 15; 13(4):505-11. PubMed ID: 19145671
    [Abstract] [Full Text] [Related]

  • 15. Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: a phase II study.
    Pectasides D, Pectasides M, Farmakis D, Gaglia A, Koumarianou A, Nikolaou M, Koumpou M, Kountourakis P, Papaxoinis G, Mitrou P, Economopoulos T, Raptis SA.
    Gynecol Oncol; 2004 Oct 15; 95(1):165-72. PubMed ID: 15385127
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.
    Lim JY, Cho JY, Oh KJ, Choi SH, Lee SI, Jeung HC.
    Chemotherapy; 2009 Oct 15; 55(4):200-6. PubMed ID: 19451710
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
    Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, Dromain C, Pocard M, Ducreux M.
    Ann Surg Oncol; 2008 Jan 15; 15(1):219-26. PubMed ID: 17896145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.